Anatomical Therapeutic Chemical • N07XX25 • omaveloxolon

A Alimentary tract and metabolism

B Blood and blood forming organs

C Cardiovascular system

D Dermatologicals

G Genito urinary system and sex hormones

H Systemic hormonal preparations, excluding sex hormones and insulins

J Antiinfectives for systemic use

L Antineoplastic and immunomodulating agents

M Musculo-skeletal system

N Nervous system

N01 Anesthetics

N02 Analgesics

N03 Antiepileptics

N04 Anti-parkinson drugs

N05 Psycholeptics

N06 Psychoanaleptics

N07 Other nervous system drugs

N07A Parasympathomimetics

N07B Drugs used in addictive disorders

N07C Antivertigo preparations

N07X Other nervous system drugs

N07XA Gangliosides and ganglioside derivatives

N07XX Other nervous system drugs

N07XX02 riluzole Indicated for: amyotrophic lateral sclerosis

N07XX04 sodium oxybate Indicated for: narcolepsy; excessive daytime sleepiness

N07XX06 tetrabenazine Indicated for: chorea in Huntington disease

N07XX07 fampridine Indicated for: walking impairment in multiple sclerosis

N07XX08 tafamidis Indicated for: transthyretin amyloidosis

N07XX11 pitolisant Indicated for: narcolepsy; excessive daytime sleepiness

N07XX12 patisiran Indicated for: transthyretin amyloidosis

N07XX15 inotersen Indicated for: transthyretin amyloidosis

N07XX18 vutrisiran Indicated for: hereditary transthyretin-mediated amyloidosis

N07XX21 eplontersen Indicated for: transthyretin amyloidosis

N07XX22 tofersen Indicated for: amyotrophic lateral sclerosis associated with SOD1 mutation

N07XX25 omaveloxolon Indicated for: Friedreich ataxia

N07XXN3 hydrolyzed protein from porcine brain Indicated for: cognitive disorders; cerebral metabolic support

P Antiparasitic products, insecticides and repellents

R Respiratory system

S Sensory organs

V Various